3644 results for «2796»
3644 results
Bleeding and thrombotic risk in LAA closure patients
20 May 2026 – From EuroPCR 2026
This session provides a thorough examination of bleeding and thrombotic risks in patients undergoing left atrial appendage (LAA) closure. It reviews risk factors for device-related thrombosis, compares anticoagulation strategies post-procedure, and presents real-world clinical outcomes, particularly in high bleeding risk populations and special groups such as...
Optimising bifurcation PCI: learning from randomised controlled trials
20 May 2026 – From EuroPCR 2026
This session delves into optimizing bifurcation PCI by examining contemporary European practices and outcomes from multiple randomized controlled trials. Key topics include multivessel TALENT trial results, 30-day outcomes of left main PCI with sirolimus-eluting stents from the NAGOMI COMPLEX study, comparative insights from the CROSS-LCX Registry...
Challenging TAVI access: exploring transfemoral boundaries and mastering alternative access
20 May 2026 – From EuroPCR 2026
This session investigates the boundaries of transfemoral access for TAVI and strategies to safely extend its use. It also provides a comprehensive review of facilitated transfemoral TAVI techniques and explores alternative access options, offering critical insights for managing challenging TAVI cases.
TAVI: head-to-head trials
20 May 2026 – From EuroPCR 2026
This session presents head-to-head comparisons of TAVI devices from recent randomized trials and registries. Highlights include three-year outcomes from the SMART trial, two-year data from the LANDMARK trial on contemporary valves, comparisons of intra- and supra-annular self-expanding valves, evaluations in large annuli, the ALLEGRA trial focusing...
Lost, crushed, fractured: stent complications in real life
20 May 2026 – From EuroPCR 2026
This session addresses real-world challenges of stent complications including loss, crushing, and fracture during PCI. Through case-based discussions, it explores complex scenarios such as stent dislodgement, embolisation, and management strategies when initial plans evolve into complicated realities.
All you need to know about interventional therapies for pulmonary embolism
20 May 2026 – From EuroPCR 2026
Focused on interventional therapies for pulmonary embolism, this session guides on establishing and sustaining Pulmonary Embolism Response Teams (PERT), refining patient selection for intervention, choosing appropriate technologies, and identifying intraprocedural markers indicating successful treatment outcomes.
Antithrombotic therapy after TAVI: optimal agents, regimens, and patient selection
20 May 2026 – From EuroPCR 2026
This session critically evaluates antithrombotic therapy following TAVI, addressing optimal agents and regimens tailored to patients with and without atrial fibrillation. It also reviews clinical presentations and management of valve thrombosis post-TAVI, using guideline-based approaches and real-world cases to individualize patient care.
Unusual complexities, uncommon complications and innovative solutions
20 May 2026 – From EuroPCR 2026
This session showcases innovative solutions to unusual complexities and rare complications in interventional cardiology. Through detailed case presentations, it examines ambiguous CTO management, giant coronary aneurysm complications post-PCI, and unforeseen issues arising from coronary atherectomy for calcified nodules.
Complex left main patients and PCI
20 May 2026 – From EuroPCR 2026
This session addressed the complexities of left main PCI, focusing on managing hemodynamic uncertainty in high-risk interventions, advanced techniques such as ultra-low contrast rota-tripsy PCI, precise stent positioning, and pragmatic approaches to CHIP cases, emphasizing contrast-sparing strategies and best practice balancing.
Other valvular and structural interventions
20 May 2026 – From EuroPCR 2026
Covering a spectrum of valvular and structural heart interventions, this session discusses systemic aortic valve TEER in complex congenital cases, compares TAVI and surgical AVR outcomes via meta-analysis, highlights radiation protection advances in complex endovascular repair, and presents combined mitral and tricuspid TEER techniques, novel ultrasound...
TAVI for aortic regurgitation
20 May 2026 – From EuroPCR 2026
This session highlights innovative transcatheter aortic valve implantation (TAVI) approaches for treating aortic regurgitation, focusing on off-label uses and complex cases. It features high-risk patient interventions, including nonagenarian patients, and strategies to manage severe non-calcific native valve regurgitation with balloon-expandable valves.
Transcatheter rescue in cardiogenic shock
20 May 2026 – From EuroPCR 2026
This session presents cutting-edge transcatheter rescue interventions in cardiogenic shock scenarios. It covers emergent valve-in-valve procedures, hybrid approaches for valvular heart disease with heart failure, management of ventricular septal rupture post-myocardial infarction, and percutaneous closure techniques for high-risk patients, emphasizing lifesaving interventional strategies.
New data in DCB outcomes
20 May 2026 – From EuroPCR 2026
Explore emerging evidence on drug-coated balloon (DCB) outcomes, featuring intravascular lithotripsy combined with DCB in calcified small vessels, OCT-guided PCI registries, predictors of angiographic success post-sirolimus-coated balloon angioplasty, and clinical impact in multivessel coronary artery disease management.
Complications in CAD PCI
20 May 2026 – From EuroPCR 2026
This session focuses on the recognition and management of complications during coronary artery disease PCI. It includes cases of acute guide catheter crises, rare post-PCI chest pain etiologies, innovative stent retrieval techniques, and critical procedural challenges, providing an educational journey through complex complication management.
New frontiers - The evolving role of nurses and allied professionals
20 May 2026 – From EuroPCR 2026
This session explores the evolving role of nurses and allied professionals in interventional cardiology, addressing challenges in role definitions, collaborative responsibilities with physicians, and strategies for professional recognition and safety enhancement within the cath lab environment.
Redo TAVI challenges
20 May 2026 – From EuroPCR 2026
Focused on the complexities of redo transcatheter aortic valve implantation (TAVI), this session covers innovative techniques such as jailed-balloon to prevent sinus sequestration, CT-guided emergency valve-in-valve procedures, alternative access routes, and strategies to manage coronary occlusion risks during multiple valve interventions.
AI adoption in the cathlab of tomorrow - Intravascular imaging applications
20 May 2026 – From EuroPCR 2026
This session examines the integration of artificial intelligence in intravascular imaging within the cath lab, identifying unmet needs in OCT interpretation, exploring AI's role in enhancing procedural decision-making and trust, and discussing barriers to implementation such as prediction reliability and clinical actionability.
Imaging guidance in everyday practice
20 May 2026 – From EuroPCR 2026
This session emphasizes the role of imaging guidance in everyday interventional cardiology practice. Through challenging cases involving exertional chest pain, unusual coronary anatomy, complex left ventricular access, side branch navigation, and IVUS-guided re-intervention, it underscores the critical value of advanced imaging for diagnostic clarity and procedural...
When transfemoral is not an option: is TAVI still possible?
20 May 2026 – From EuroPCR 2026
This session explores alternative access strategies for Transcatheter Aortic Valve Implantation (TAVI) when the transfemoral route is not feasible. It covers complex scenarios including transcaval TAVI complications, transaxillary approaches, management of extra-large annuli with peripheral artery disease, and innovative transcarotid valve-in-valve procedures.
Coronary interventions: first-in-man and novel devices
20 May 2026 – From EuroPCR 2026
Explore pioneering advancements in coronary interventions with first-in-man and novel devices. This session presents groundbreaking studies including cryotherapy for vulnerable plaques, a novel intravascular crossing system for coronary CTOs, sirolimus-coated retrievable scaffold therapy for in-stent restenosis, real-time intravascular photoacoustic imaging of lipid-rich plaques, and the inaugural...